Health Canada Advises Allergan Of Its Intent To Suspend Its Licences For Biocell Breast Implants As A Precautionary Measure
Allergan Biocell Breast Implants Recall Summary Health Canada is suspending licences for Allergan's Biocell breast implants as a precautionary safety measure. This affects all Biocell breast implants that have been distributed across Canada. The suspension applies to all Canadian patients and healthcare providers who use or work with this product.
- Reason
- Product safety
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2019-04-04
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/de48feca-9444-4ac7-a4b5-122feb147df5